Azimuth Capital Investment Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-82,650
Closed -$5.54M 305
2024
Q3
$5.54M Sell
82,650
-73,005
-47% -$6M 0.22% 139
2024
Q2
$17.6M Sell
155,655
-158
-0.1% -$20K 0.72% 42
2024
Q1
$21.6M Buy
155,813
+19,013
+14% +$2.39M 0.89% 30
2023
Q4
$17M Sell
136,800
-59,266
-30% -$6.05M 0.77% 44
2023
Q3
$18.3M Buy
196,066
+140,433
+252% +$15.8M 0.9% 30
2023
Q2
$7.15M Buy
+55,633
New +$6.73M 0.34% 114

Other funds holding DXCM

Azimuth Capital Investment Management's DXCM Position: Q4 2024 in Review

Azimuth Capital Investment Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 82,650 shares — an estimated $5.54M sold.

Azimuth Capital Investment Management first reported a position in DXCM in Q2 2023 and held it in 6 quarters. The position peaked at $21.6M in Q1 2024. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Azimuth Capital Investment Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • Azimuth Capital Investment Management sold 82,650 DexCom shares in Q4 2024, an estimated $5.54M.
  • Azimuth Capital Investment Management first reported a position in DexCom in Q2 2023 and held it in 6 quarters.
  • Azimuth Capital Investment Management's DexCom position peaked at $21.6M in Q1 2024.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Azimuth Capital Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.